Shares CARA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 17th, 2014 • Cara Therapeutics, Inc. • Pharmaceutical preparations • New York
Cara Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of shares (the “Firm Shares”) of the common stock, par value $0.001 per share, of the Company (“Common Stock”). The Company also proposes to sell to the several Underwriters, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, up to an additional shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
INDEMNIFICATION AGREEMENTIndemnification Agreement • January 17th, 2014 • Cara Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement, dated as of (this “Agreement”), is made by and between Cara Therapeutics, Inc., a Delaware corporation (the “Company”) and (“Indemnitee”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 17th, 2014 • Cara Therapeutics, Inc. • Pharmaceutical preparations • Connecticut
This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective [Date] (the “Effective Date”), by and between Frédérique Menzaghi (“Executive”) and Cara Therapeutics, Inc. (the “Company”).
SERVICES AGREEMENTServices Agreement • January 17th, 2014 • Cara Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SERVICES AGREEMENT (“Agreement”), is entered into as of July 2, 2004, by and between CARA THERAPEUTICS, INC., a Delaware corporation (“Cara”), and BIO DILIGENCE PARTNERS, INC., a Pennsylvania corporation (“Consultant”).
